IL17A and geroderma osteodysplastica: Elevated serum levels of IL-17A, IL-23, and IL-6 have been observed in GO patients, highlighting the significance of the Th17 pathway and IL-23/IL-17 axis in the progression of this condition (Kim et al., 2012a; Fang et al., 2016).